Literature DB >> 35941857

Expression and Significance of TNF-α and NF-κB/p65 in Cutaneous Lichen Planus.

Jun Fang Chen1, Xue Mei Zhang1,2, Kiran Sanjel1,2, Juan Zhang2, Cong Ma1.   

Abstract

Purpose: The purpose of this study was to explore the expression of TNF-α and NF-κB/p65 in Lichen planus skin lesions and their correlation with the pathogenesis of Lichen planus. Patients and
Methods: The case group consisted of 30 individuals diagnosed with LP based on clinical and histopathologic examination. The control group consisted of 10 individuals from an Orthopedic Department with normal skin. TNF-α and NF-κB/p65 expression in skin tissue samples was detected by immunohistochemistry.
Results: The immunohistochemical results showed that TNF-α and NF-κB/p65 expression levels were significantly higher in LP skin lesions than normal skin tissues (P ≤ 0.05). Positive TNF-α staining mainly occurred in the cytoplasm of keratinocytes of the stratum granulosum, stratum spinosum, and stratum basale in the epidermis and lymphocytes in the superficial dermis. Positive NF-κB/p65 staining mainly occurred in the nucleus and cytoplasm of keratinocytes of the stratum spinosum and stratum basale in the epidermis and lymphocytes in the superficial dermis.
Conclusion: TNF-α and NF-κB/p65 are overexpressed in cutaneous LP. The two are positively correlated in LP, suggesting that they both play essential roles in the pathogenesis of LP.
© 2022 Chen et al.

Entities:  

Keywords:  NF-κB/p65; TNF-α; immunohistochemistry; lichen planus; staining

Year:  2022        PMID: 35941857      PMCID: PMC9356624          DOI: 10.2147/CCID.S372662

Source DB:  PubMed          Journal:  Clin Cosmet Investig Dermatol        ISSN: 1178-7015


  17 in total

1.  Etanercept for the management of oral lichen planus.

Authors:  Noam Yarom
Journal:  Am J Clin Dermatol       Date:  2007       Impact factor: 7.403

Review 2.  Lichenoid drug eruption caused by adalimumab: a case report and literature review.

Authors:  Akiha Inoue; Yu Sawada; Takashi Yamaguchi; Shun Ohmori; Daisuke Omoto; Sanehito Haruyama; Manabu Yoshioka; Etsuko Okada; Motonobu Nakamura
Journal:  Eur J Dermatol       Date:  2017-02-01       Impact factor: 3.328

3.  Association between -308 G/A polymorphism in TNF-α gene and lichen planus: a meta-analysis.

Authors:  Xin Jin; Jiayi Wang; Lili Zhu; Lili Wang; Hongxia Dan; Xin Zeng; Qianming Chen
Journal:  J Dermatol Sci       Date:  2012-09-13       Impact factor: 4.563

4.  Experimental study on 1,25(OH)2 D3 amelioration of oral lichen planus through regulating NF-κB signaling pathway.

Authors:  J Du; R Li; F Yu; F Yang; J Wang; Q Chen; X Wang; B Zhao; F Zhang
Journal:  Oral Dis       Date:  2017-03-30       Impact factor: 3.511

5.  Adalimumab in the management of cutaneous and oral lichen planus.

Authors:  Tomas J Chao
Journal:  Cutis       Date:  2009-12

6.  Nail Lichen Planus: Successful Treatment with Etanercept.

Authors:  N Irla; T Schneiter; E Haneke; N Yawalkar
Journal:  Case Rep Dermatol       Date:  2010-10-21

Review 7.  The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

Authors:  Consuelo M López de Padilla; Timothy B Niewold
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

8.  The Measurement of Serum Tumor Necrosis Factor-alpha Levels in Patients with Lichen Planus.

Authors:  Yesim Akpinar Kara
Journal:  Indian J Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.494

9.  Dimethyl Fumarate Targets MSK1, RSK1, 2 and IKKα/β Kinases and Regulates NF-κB /p65 Activation in Psoriasis: A Demonstration of the Effect on Peripheral Blood Mononuclear Cells, Drawn from Two Patients with Severe Psoriasis Before and After Treatment with Dimethyl Fumarate.

Authors:  Borbala Gesser; Mads K Rasmussen; Lars Iversen
Journal:  Psoriasis (Auckl)       Date:  2020-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.